Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma.
Saved in:
| Title: | Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma. |
|---|---|
| Authors: | Gustine JN; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Branagan AR; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Cirstea DD; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Rexha F; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Han R; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Yee AJ; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Maus MV; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Frigault MJ; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Raje NS; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA. |
| Source: | Blood advances [Blood Adv] 2025 Jun 24; Vol. 9 (12), pp. 3026-3030. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
